Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT04382846

PHASE3

Novel Regimens in COVID-19 Treatment

Sponsor: Tanta University

View on ClinicalTrials.gov

Summary

Nitazoxanide has been shown to have a clinical efficacy against severe acute respiratory syndrome coronavirus 2; ivermectin has also demonstrated a remarkable experimental efficacy with a potential to be used for Coronavirus disease 2019.

Official title: Nitazoxanide in Treatment of COVID-19

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

160

Start Date

2020-05-08

Completion Date

2030-12-01

Last Updated

2020-12-04

Healthy Volunteers

Conditions

COVID Corona Virus Infection

Interventions

DRUG

Nitazoxanide

Locations (2)

Tanta University, Assiut University

Tanta, Egypt

Sherief Abd-Elsalam